Interview with Devyn Smith PhD, COO of Sigilon Therapeutics
Sigilon Therapeutics is a Cambridge, MA-based biotech company developing innovative therapeutics by encapsulating cells in a novel coating that renders them invisible to the immune system. The engineered cells contained in the company’s particles c...
Source: Medgadget - Category: Medical Devices Authors: Tom Peach Tags: Exclusive Genetics Materials Medicine Pediatrics Source Type: blogs
More News: Biology | Biotechnology | Chronic Pain | Databases & Libraries | Diabetes | Endocrinology | Environmental Health | European Medicines Agency (EMA) | Gene Therapy | Genetics | Haemophilia | Harvard | Hemophilia | Insulin | Learning | Liver | Medical Devices | Pain | Peaches | Pediatrics | Pfizer | Study | Universities & Medical Training | Urology & Nephrology | Websites